Daniel J. Kennedy is a Patent Agent in the Intellectual Property Practice Group at Haynes and Boone’s San Francisco office. Daniel has represented numerous clients in their patent prosecution matters in fields such as medical imaging, spectroscopy, optics, nuclear magnetic resonance, next generation sequencing, proteomics, cell sorting, microfluidics, quantum metrology, brain-machine interfacing, in silico drug design, artificial intelligence, software, optical computing, and quantum computing.
Before moving into patent law, Daniel obtained a Ph.D. in biophysics from the University of California, Berkeley, where he worked on leveraging optical techniques to detect nuclear magnetic resonance signals without the need for large superconducting magnets. He also completed a postdoctoral research appointment at Lawrence Livermore National Laboratory, where he worked on a variety of projects related to detecting and treating exposure to chemical and biological weapons.
Daniel is currently attending law school at the University of California, Berkeley, where he is the recipient of a Dean’s Fellowship. He expects to finish in 2022.
Selected Publications and Speeches
- “Initial Observations Regarding the USPTO’s Patents 4 Partnerships Pilot Program,” co-author, Intellectual Property & Technology Law Journal, Volume 33 No. 3, March 2021. Read here.
B.A., Mathematics and Philosophy, University of Minnesota, 2009
B.S., Physics, University of Minnesota, 2009, summa cum laude
Ph.D., Biophysics, University of California Berkeley, 2014
U.S. Patent and Trademark Office
Some months ago, the U.S. Patent and Trademark Office (“USPTO”) announced the Patents 4 Partnerships (“P4P”) platform, a pilot program that aims to connect companies who wish to acquire or license patent assets (including issued patents and pending patent applications) with the owners of those assets. The P4P program consists of a searchable database of patent assets that are voluntarily submitted [...]